List of insiders holdings for ENDOCYTE INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sanderling Venture Partners V LP SANDERLING V BETEILIGUNGS GMBH & CO KG SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP SANDERLING V BIOMEDICAL LP SANDERLING V LTD PARTNERSHIP Sanderling V Strategic Exit Fund LP Sanderling Venture Partners V Co Investment Fund LP Sanderling Venture Partners VI Co Investment Fund LP Sanderling VI Beteiligungs GmbH & Co KG Sanderling VI Limited Partnership 10% Owner | 2012-01-11 17:11:14 | 0 3,545,617 | 3,545,617 | Form 4/A |
| Pension Fund of the Christian Church (Disciples of Christ) Inc 10% Owner | 2018-01-19 16:04:21 | 2,758,063 0 | 2,758,063 | Form 13G |
| CINCINNATI FINANCIAL CORP 10% Owner | 2011-08-12 10:26:35 | 650,000 0 | 650,000 | Form 13G |
| Ellis P Ron Former Dir., Pres. and CEO | 2016-06-28 17:07:29 | 320,040 0 | 320,040 | Form 4 |
| SANDERLING VENTURES MANAGEMENT V Sanderling Ventures Management VI 10% Owner | 2012-12-13 14:30:36 | 0 182,947 | 182,947 | Form 4 |
| Harper Scot VP of CLINICAL OPERATIONS | 2016-02-08 20:48:12 | 75,035 0 | 75,035 | Form 4 |
| Meek David D. Chief Commercial Officer | 2014-02-10 18:30:53 | 52,500 0 | 52,500 | Form 4 |
| Nguyen Binh VP of Medical Affairs | 2015-03-05 16:30:20 | 48,359 0 | 48,359 | Form 4 |
| Ritter Allen R VP of Manufacturing/CMC | 2014-04-11 17:12:40 | 47,842 0 | 47,842 | Form 4 |
| BRAUER KEITH E Director | 2017-05-05 17:08:49 | 37,771 0 | 37,771 | Form 4 |
| Messmann Richard A VP of Medical Affairs | 2011-04-18 16:19:57 | 30,000 0 | 30,000 | Form 4 |
| HANHAM ANN Director | 2017-05-05 17:09:35 | 27,300 0 | 27,300 | Form 4 |
| MELDRUM PETER D Director | 2017-05-05 17:08:00 | 27,300 0 | 27,300 | Form 4 |
| Lovejoy Chandra D VP of Regulatory Affairs | 2014-08-13 17:00:25 | 23,693 0 | 23,693 | Form 4 |
| Brinkley Michael A. Vice President of Quality | 2017-02-07 19:27:18 | 23,486 0 | 23,486 | Form 4 |
| BAILEY DOUGLAS G Director | 2012-06-04 17:02:50 | 10000 0 | 10000 | Form 4 |
| Shannon James Samuel Director | 2011-05-31 16:33:18 | 10000 0 | 10000 | Form 4 |
| CLAWSON JOHN G Director | 2011-05-31 16:18:07 | 10000 0 | 10000 | Form 4 |
| MIDDLETON FRED A Director | 2018-12-21 12:54:50 | 0 0 | 0 | Form 4 |
| Machado Patrick Director | 2018-12-21 12:54:21 | 0 0 | 0 | Form 4 |
| McAvoy David R. General Counsel | 2018-12-21 12:53:49 | 0 0 | 0 | Form 4 |
| Leamon Christopher P Vice President of Research | 2018-12-21 12:53:34 | 0 0 | 0 | Form 4 |
| Armour Alison A. Chief Medical Officer | 2018-12-21 12:53:20 | 0 0 | 0 | Form 4 |
| Parker Katherine VP of Human Resources | 2018-12-21 12:53:09 | 0 0 | 0 | Form 4 |
| Russell Lesley Director | 2018-12-21 12:52:20 | 0 0 | 0 | Form 4 |
| Chelius Erik C. Vice President CMC | 2018-12-21 12:51:50 | 0 0 | 0 | Form 4 |
| APLIN JOHN C Director | 2018-12-21 12:51:10 | 0 0 | 0 | Form 4 |
| Taylor Beth VP Finance & Chief Acctg Off | 2018-12-21 12:49:37 | 0 0 | 0 | Form 4 |
| GODDARD COLIN Director | 2018-12-21 12:49:04 | 0 0 | 0 | Form 4 |
| Svoronos Dawn Director | 2018-12-21 12:48:34 | 0 0 | 0 | Form 4 |
| KOZIN MARC D Director | 2018-12-21 12:48:20 | 0 0 | 0 | Form 4 |
| Sherman Michael A. President and CEO | 2018-12-21 12:47:35 | 0 0 | 0 | Form 4 |
| Low Philip S Chief Science Officer | 2018-12-21 12:47:20 | 0 0 | 0 | Form 4 |
| Andriole Michael T. Chief Financial Officer | 2018-12-21 12:46:34 | 0 0 | 0 | Form 4 |